Latest News of CRSP
Is CRISPR Therapeutics (CRSP) a Promising Gene Editing Stock?
By Yahoo! Finance |
1 week ago
We recently listed the 10 Most Promising Gene Editing Stocks, including CRISPR Therapeutics AG. The pharmaceutical industry is driven by innovation in gene therapy and editing, with CRISPR technology ...
Is CRISPR Therapeutics AG (CRSP) the Most Promising Biotech Stock According to Hedge Funds?
By Yahoo! Finance |
3 weeks ago
Insider Monkey analyzed the most promising biotech stocks favored by hedge funds, with CRISPR Therapeutics AG (NASDAQ:CRSP) ranking among the top. Despite volatility, biotech's growth is driven by fac...
CRISPR Therapeutics AG (CRSP): Among the Worst ARK Stocks According to Short Sellers
By Yahoo! Finance |
1 month ago
The article discusses ARK stocks and Cathie Wood's investment approach, focusing on disruptive innovation. It highlights CRISPR Therapeutics AG (NASDAQ:CRSP) and its potential in the gene sequencing i...
-
CRISPR Therapeutics AG (CRSP) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance | 3 months agoCRISPR Therapeutics AG is a gene editing company using CRISPR/Cas9 technology to develop gene-based medicines for various diseases. Their lead product, CASGEVY, aims to treat genetic blood disorders b...
-
CRISPR Therapeutics AG (CRSP) Stock Price, News, Quote & History
By Yahoo! Finance | 3 months agoCRISPR Therapeutics AG is a gene editing company developing gene-based medicines for various diseases using its CRISPR/Cas9 platform. Their lead product candidate, CASGEVY, focuses on treating hemoglo...
-
Is CRISPR Therapeutics AG (CRSP) the Best Stock to Buy and Hold for 5 Years?
By Yahoo! Finance | 4 months agoInsider Monkey analyzed Cathie Wood's top stock picks for long-term investment. CRISPR Therapeutics AG (NASDAQ:CRSP) is highlighted as a revolutionary player in genetic sequencing. The company's poten...
-
CRISPR Therapeutics Stock (NASDAQ:CRSP): Will It Take Off Anytime Soon?
By Yahoo! Finance | 4 months agoCRISPR Therapeutics shows promise in gene therapy with its groundbreaking treatments for genetic diseases. Despite challenges like establishing treatment centers and gaining long-term data, the compan...